DNAprint Genomics (DNAG)

[ann441j]

Wall St. Reporter Interview available til Nov. '06:

Mr. Gabriel also gave insights into the revenue potential for DNA research and an update on the development of compounds to treat various diseases. He elaborated on the revenue potential for the Company's relationships with Biofrontera of Germany, in which the company has a significant ownership stake, as well as the continuing relationship with Harvard University's Beth Israel Deaconess Hospital and the new relationship with Emory University's Center for Medical Genomics.

The interview is available for streaming by going to http://www.wallstreetreporter.com/profile.php?id=19412. Free registration is required to enter the site. The interview will be available in the site's archive until November 15, 2006.

ANN